Merck, in partnership with NJII, announced the launch of the Merck Digital Sciences Studio to enable the generation of innovative technologies for drug discovery and development.

emPOLST is a statewide central repository for POLST, or Practitioners Orders for Life Sustaining Treatment, a healthcare planning tool that empowers individuals to work closely with their medical team to detail their goals for end-of-life care.

Brick City Entrepreneurship Training is a six-week, part-time bootcamp that trains multicultural entrepreneurs in foundational entrepreneurial skills to become a high-growth, technology startup founder or a main-street, small business founder.  

New Jersey Innovation Institute (NJII) announced the sale of its subsidiary, BioCentriq Inc., to GC corp. for $73 million. BioCentriq manufactures autologous and allogeneic cell therapies and gene therapies and specializes in viral vector production, cell and viral banking, and upstream and downstream processing.

Frantz Romain is the co-founder and CTO of PROFIT, a free banking and accounting solution for small businesses. He is also a 2016 NJIT graduate with a degree in Information Systems and a serious passion …

The digital transformation has hit the manufacturing floor. Learn more at the NJIT Industry 4.0 & Smart Manufacturing panel discussion.

The digital transformation has hit the manufacturing floor. Learn more at the NJIT Industry 4.0 & Smart Manufacturing panel discussion.

The digital transformation has hit the manufacturing floor. Learn more at the NJIT Industry 4.0 & Smart Manufacturing panel discussion.

The digital transformation has hit the manufacturing floor. Learn more at the NJIT Industry 4.0 & Smart Manufacturing panel discussion.

The digital transformation has hit the manufacturing floor. Learn more at the NJIT Industry 4.0 & Smart Manufacturing panel discussion.

New Jersey Innovation Institute (NJII) announced today that it has joined the Strategic Health Information Exchange Collaborative (SHIEC).

NJII announces partnership with McKinsey & Company in the launch of a new center to advance operations and manufacturing excellence in cell and gene therapy (CGT).